Cancer, type 2 diabetes, and ageing: news from flies and worms

E Hafen1

  • 1Zoologisches Institut, Universität Zürich, Switzerland. hafen@zool.unizh.ch

Swiss Medical Weekly
|January 7, 2005
PubMed

Insights

Model organism genetics research has illuminated the roles of PTEN, TSC1/TSC2 tumor suppressors, and nutrient-sensing pathways like Insulin/IGF signaling (IIS) and Target of Rapamycin (TOR) in cellular growth and cancer. This work highlights conserved mechanisms for therapeutic targeting.

Area of Science:

  • Genetics and Developmental Biology
  • Cancer Biology
  • Molecular Signaling

Background:

  • The tumor suppressor gene PTEN is frequently mutated in human cancers.
  • Mutations in TSC1 and TSC2 genes cause Tuberous Sclerosis, characterized by benign brain tumors.
  • Understanding cellular growth control is crucial for cancer therapy.

Purpose of the Study:

  • To review the contributions of model organism genetics to understanding tumor suppressor pathways.
  • To highlight the role of Insulin/IGF (IIS) and Target of Rapamycin (TOR) signaling in growth control.
  • To emphasize the evolutionary conservation of nutrient-dependent growth regulation.

Main Methods:

  • Genetic dissection of cell and organism growth pathways in Drosophila.
  • Studies on nutrient regulation of growth and aging in Caenorhabditis elegans.
  • Review of existing literature on model organism contributions to signaling pathway research.

Main Results:

  • Model organisms have been instrumental in dissecting pathways controlled by tumor suppressors like PTEN and TSC1/TSC2.
  • Evidence from model organisms has established the central role of IIS and TOR signaling in cellular growth.
  • Nutrient-dependent growth regulation mechanisms are evolutionarily conserved across species.

Conclusions:

  • Model organism genetics provides critical insights into human diseases like cancer and Tuberous Sclerosis.
  • The IIS and TOR pathways are key regulators of cellular growth and represent promising cancer therapeutic targets.
  • Understanding conserved nutrient-sensing pathways can inform novel treatment strategies.

Related Concept Videos

Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.